-
Evora Biosciences
Created in 2020
-
-
Up & running (A)
Existing signals show a regular activity -
Social networks
1,578 -
Activities
-
Technologies
-
Entity types
-
Location
Strasbourg, France
Strasbourg
France
-
Employees
Scale: 2-10
Estimated: 5
-
SIREN
882655699 -
Engaged catalyst
6
0 0 -
Added in Motherbase
2 years, 8 months ago
-
Value proposition
First-in-class immunomodulatory peptides.
Evora Biosciences develops novel immunomodulatory peptides with the aim to bring first-in-class treatments to patients in areas of high unmet need.
immunodermatology, peptides, inflammatory diseases, respiratory diseases, inflammation, and immunomodulation -
Original language
First-in-class immunomodulatory peptides.
Evora Biosciences develops novel immunomodulatory peptides with the aim to bring first-in-class treatments to patients in areas of high unmet need.
-
Evora Biosciences – Novel immunomodulatory peptides
https://www.evorabio.com/
| Catalyst | Type | Tweets | Articles | |
|---|---|---|---|---|
Quest for health
Startup accelerator & VC, Business Consulting and Services (Auto) |
Quest for health
Startup accelerator & VC, Business Consulting and Services (Auto) |
Other
30 Nov 2023 |
|
|
HTGF | High-Tech Gründerfonds
Venture Capital and Private Equity Principals (Auto) |
HTGF | High-Tech Gründerfonds
Venture Capital and Private Equity Principals (Auto) |
Other
16 Oct 2024 |
|
|
BioValley France
Public business cluster, Biotechnology, French Cluster |
BioValley France
Public business cluster, Biotechnology, French Cluster |
Other
14 Mar 2024 |
|
|
Johnson & Johnson
Pharmaceutical, Hospitals and Health Care (Auto) |
Johnson & Johnson
Pharmaceutical, Hospitals and Health Care (Auto) |
Other
30 Apr 2023 |
|
|
Erganeo
Research, National and local authorities, Research Services (Auto) |
Erganeo
Research, National and local authorities, Research Services (Auto) |
Other
22 Jun 2023 |
|
|
CNRS Innovation
Research |
CNRS Innovation
Research |
Other
29 Jun 2023 |
|
|